Circular RNA MYLK as a com⁃ peting endogenous RNA promotes bladder cancer progression through modulating VEGFA / VEGFR2 signaling pathway [ J ] . Cancer Lett, 2017,403:305⁃317.Zhong Z, Huang M, Lv M, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer ...
中图分类号：R735.2 文献标志码：A 文章编号：1007-3639(2020)02-0113-09 Dihydromyricetin inhibits gastric cancer angiogenesis in vitro and in vivo through ERK/VEGFA/VEGFR2 signaling pathway WEN Peinan 1, LIN Mingshu 1, JIN Mian 1, XU Xianchou 1, CHEN Longyun 2 (1. Department ...
Here we report that VEGFR2 regulates cancer-induced angiogenesis and EMT-linked stemness in CC cells via AKT/GSK3β/β-catenin and Snail pathway. Receptor tyrosine kinase inhibitor (RTKi) of VEGFR, Pazopanib (PAZ), shows potential anti-VEGFR2 activity and inhibits VEGFa induced metastatic events...
Downstream RhoB-VEGFA signaling pathway was validated by siRhoB and siVEGFA inhibition. In a word, CCL24 contributes to HCC malignancy via RhoB-VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis, which urges us to study further CCL24 effects on diagnosis and potential therapy for HCC...
recommended VEGFA antibody (AA 1-147)(ABIN6150086) VEGFAReactivity: HumanWBHost: RabbitPolyclonalunconjugated recommended VEGFA antibody (AA 28-147)(ABIN7429445) VEGFAReactivity: HumanWB, IHC, IP, ICCHost: RabbitPolyclonalunconjugated recommended ...
Effect of Babao Dan on angiogenesis of gastric cancer in vitro by regulating VEGFA/VEGFR2 signaling pathwaydoi:10.21037/TCR-20-2559Jian-Hua GuanZhi-Yun CaoBin GuanLi-Hui WeiJun PengYou-Qin ChenThomas Joseph SferraSenthilkumar Sankararaman
In conclusion, the results of our study indicate that genetic polymorphisms in VEGFA mediated pathway may influence the susceptibility to CLL.JoannaGóra-TyborJanuszSzemrajTadeuszRobakKrzysztofJamroziakSDOSBlood Cells Molecules & DiseasesGora-Tybor J, Szemraj J, Robak T, Jamroziak K. Clinical ...
OBJECTIVE: To evaluate the pharmacogenetic relationship between genotypes of single-nucleotide polymorphisms (SNPs) in the VEGF signaling pathway and response to treatment with ranibizumab or bevacizumab for neovascular age-related macular degeneration. DESIGN, SETTING, AND PARTICIPANTS: In total, 835 of ...